You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators

https://doi.org/10.1136/gut.2011.239889

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Disclosures Dr B Oldenburg has received an unrestricted grant from MSD and Abbott Immunology. Dr M G H van Oijen has received an unrestricted research grant and has served as a consultant for Abbott Immunology.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.